Comment
doi: 10.1016/S1473-3099(20)30640-X.
It's worse than we thought: the US market for novel Gram-negative antibiotics
Affiliations
- PMID: 32860761
- DOI: 10.1016/S1473-3099(20)30640-X
Item in Clipboard
Comment
It's worse than we thought: the US market for novel Gram-negative antibiotics
Lancet Infect Dis.
2020 Sep.
No abstract available
Comment on
-
Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.Lancet Infect Dis. 2020 Oct;20(10):1172-1181. doi: 10.1016/S1473-3099(20)30153-5. Epub 2020 Jun 4. Lancet Infect Dis. 2020. PMID: 32505231 Free PMC article.
Similar articles
-
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.Int J Antimicrob Agents. 2016 Nov;48(5):498-503. doi: 10.1016/j.ijantimicag.2016.07.013. Epub 2016 Aug 20. Int J Antimicrob Agents. 2016. PMID: 27590704
-
Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.J Microbiol Immunol Infect. 2016 Feb;49(1):74-82. doi: 10.1016/j.jmii.2015.05.011. Epub 2015 Jun 27. J Microbiol Immunol Infect. 2016. PMID: 26586483
-
Polymyxin antibiotics for gram-negative infections.Am J Health Syst Pharm. 2007 Apr 15;64(8):819-26. doi: 10.2146/ajhp060473. Am J Health Syst Pharm. 2007. PMID: 17420197 Review.
-
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378. Clin Infect Dis. 2018. PMID: 30052813 Free PMC article.
-
Antibiotic resistance: it's bad, but why isn't it worse?BMC Biol. 2017 Sep 15;15(1):84. doi: 10.1186/s12915-017-0423-1. BMC Biol. 2017. PMID: 28915805 Free PMC article. Review.
Cited by
-
Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.Clin Infect Dis. 2022 Apr 9;74(7):1183-1190. doi: 10.1093/cid/ciab612. Clin Infect Dis. 2022. PMID: 34251436 Free PMC article.
-
Beyond COVID-19-a paradigm shift in infection management?Lancet Infect Dis. 2021 May;21(5):e117. doi: 10.1016/S1473-3099(20)30789-1. Epub 2020 Oct 9. Lancet Infect Dis. 2021. PMID: 33045187 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
